i&i Bio
Venture capital
UncertainLast verified 7 Nov 2026
i&i Bio is an early-stage life sciences venture capital fund backing European startups across drug discovery, medtech, diagnostics, and AI, with tickets typically between €150k and €2M.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Pre-seed, Seed
- Sectors
- Biotech & pharma, Medtech, AI & machine learning
- Ticket
- €150K–€2M
- Eligible countries
- Not stated
- Provider based in
- Czechia
- Timing
- Rolling applications
- Focus
- drug discovery; medtech; diagnostics; AI verticals; unmet medical needs
- How to apply
- Apply route unknown
- Source
- https://www.inibio.eu/
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
we are one of the very few VC funds in Europe focused exclusively on life science ventures.
https://www.inibio.eu/ - Sectors
As a life sciences fund, we are comfortable with drug discovery, medtech, diagnostics, and AI verticals.
https://www.inibio.eu/ - Ticket
We can start at €150k to support business creation. Ready to grow? Our sweet spot lies between €0.5M and €2M.
https://www.inibio.eu/ - Ticket
We can start at €150k to support business creation. Ready to grow? Our sweet spot lies between €0.5M and €2M.
https://www.inibio.eu/
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at i&i Bio? Claim this profile to confirm what you invest in.